Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials

Clinical Pharmacokinetics
Vincent MadelainFrance Mentré

Abstract

The 2014-2015 outbreak of Ebola virus disease is the largest epidemic to date in terms of the number of cases, deaths, and affected areas. In October 2015, no antiviral agents had proven antiviral efficacy in patients. However, in September 2014, the World Health Organization inventoried and has since regularly updated a list of potential drug candidates with demonstrated antiviral efficacy in in vitro or animal models. This includes agents belonging to various therapeutic classes, namely direct antiviral agents (favipiravir and BCX4430), a combination of antibodies (ZMapp), type I interferons, RNA interference-based drugs (TKM-Ebola and AVI-7537), and anticoagulant drugs (rNAPc2). Here, we review the pharmacokinetic and pharmacodynamic information presently available for these drugs, using data obtained in healthy volunteers for pharmacokinetics and data obtained in human clinical trials or animal models for pharmacodynamics. Future studies evaluating these drugs in clinical trials are critical to confirm their efficacy in humans, propose appropriate doses, and evaluate the possibility of treatment combinations.

References

May 1, 1987·Journal of Clinical Pharmacology·E RadwanskiN Zampaglione
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·P StassensG P Vlasuk
Mar 4, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·T W GeisbertP B Jahrling
Dec 29, 2004·Growth Factors·Joseph BekiszKathryn C Zoon
Jun 30, 2007·Journal of the American College of Cardiology·Robert P GiuglianoUNKNOWN ANTHEM-TIMI-32 Investigators
Dec 6, 2007·The Journal of Infectious Diseases·Daniel G BauschPierre E Rollin
Jan 23, 2009·Nature·Daniela Castanotto, John J Rossi
Jun 16, 2009·Antiviral Research·M Javad AmanSina Bavari
Aug 22, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Christopher F Basler, Gaya K Amarasinghe
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mike C WolfBenhur Lee
Mar 10, 2010·Antimicrobial Agents and Chemotherapy·Travis K WarrenSina Bavari
Nov 19, 2010·Lancet·Heinz Feldmann, Thomas W Geisbert
Jan 29, 2011·Journal of Virology·Arnab BasuTerry L Bowlin
Dec 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Larry ZeitlinGene G Olinger
Apr 10, 2012·Pharmacology & Therapeutics·Peter M GeorgeJane A Mitchell
Mar 1, 2011·Expert Opinion on Drug Discovery·Amy C ShurtleffSina Bavari
Oct 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Gene Garrard OlingerLarry Zeitlin
Dec 21, 2012·The Journal of Infectious Diseases·Lauren M SmithChristopher L Karp
May 21, 2013·Expert Opinion on Drug Metabolism & Toxicology·Derek J Roberts, Richard I Hall
Jul 3, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jin Huk Choi, Maria A Croyle
Oct 3, 2013·Antiviral Research·Yousuke FurutaDale L Barnard
Apr 9, 2014·The Journal of Antimicrobial Chemotherapy·Gerrit GehringThomas von Hahn
Apr 20, 2014·Expert Review of Clinical Immunology·Gary WongXiangguo Qiu

❮ Previous
Next ❯

Citations

Sep 1, 2016·Annual Review of Virology·M L BoisenL M Branco
Feb 24, 2017·PLoS Neglected Tropical Diseases·Thi Huyen Tram NguyenUNKNOWN JIKI study group
Nov 1, 2016·Antimicrobial Agents and Chemotherapy·Vincent MadelainHervé Raoul
May 3, 2016·F1000Research·Sean EkinsCarolina Andrade
Feb 7, 2019·Current Opinion in Infectious Diseases·Frederick G Hayden, Nahoko Shindo
Nov 16, 2018·Journal of Medical Virology·Muhammad Usman MirzaMuhammad Idrees
Jan 15, 2019·Voprosy virusologii·T E SizikovaV N Lebedev
Apr 5, 2020·Clinical Pharmacology and Therapeutics·Yin-Xiao Du, Xiao-Ping Chen
Mar 24, 2020·BMJ Global Health·Sima RugarabamuGerald Misinzo
Mar 22, 2020·CPT: Pharmacometrics & Systems Pharmacology·Vincent MadelainJérémie Guedj
Apr 8, 2020·Pharmacotherapy·Ashley BarlowMojdeh S Heavner
May 30, 2020·International Journal of Molecular Medicine·George Mihai NitulescuAristidis Tsatsakis
Sep 21, 2016·Bulletin de la Société de pathologie exotique·P Buchy
Aug 25, 2020·Current Pharmacology Reports·Puja KumariLekha Saha
Aug 23, 2017·Scientific Reports·Van Kinh Nguyen, Esteban A Hernandez-Vargas
Jul 19, 2018·BMC Public Health·Van Kinh NguyenEsteban Abelardo Hernandez-Vargas
Jul 19, 2020·British Journal of Pharmacology·Sophie L PenmanAmy E Chadwick
Aug 31, 2020·NPJ Genomic Medicine·Takuto TakahashiPamala A Jacobson
Aug 18, 2020·Drug Design, Development and Therapy·Lu LiXiaoyang Lu
Jun 17, 2020·The Tohoku Journal of Experimental Medicine·Eikan MishimaTakaaki Abe
May 3, 2018·Protein Engineering, Design & Selection : PEDS·Xiufeng WuStephen J Demarest
Nov 2, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Shashank JoshiHanmant Barkate
Nov 13, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Faryal KhamisIbrahim Al-Zakwani
Nov 23, 2020·International Immunopharmacology·Mohadeseh Haji AbdolvahabLeila Farahmand
Jan 7, 2021·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Shingo YamazakiItsuko Ishii
Jan 17, 2021·Journal of Clinical Medicine·Ryta ŁagockaAndrzej Pawlik
Dec 29, 2020·Infection and Drug Resistance·Rimple Jeet KaurSanjeev Misra
Feb 16, 2021·World Journal of Virology·Asim KichlooAkif Kichloo
Dec 15, 2020·Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia·Lucas Lobato Acatauassu Nunes, Tácio de Mendonça Lima
Dec 29, 2020·World Journal of Gastroenterology : WJG·Amr Shaaban Hanafy, Sherief Abd-Elsalam
Feb 18, 2021·Expert Opinion on Investigational Drugs·Frederick HansenMichael A Jarvis
Feb 13, 2021·NPJ Genomic Medicine·Takuto TakahashiPamala A Jacobson
Mar 21, 2021·Nature Communications·Jean-Sélim DriouichAntoine Nougairède
Mar 26, 2021·Frontiers in Pharmacology·Omkar IndariHem Chandra Jha
Mar 24, 2021·Biopharmaceutics & Drug Disposition·Nobumitsu HaniokaToshiko Tanaka-Kagawa
Mar 30, 2021·Microchemical Journal, Devoted to the Application of Microtechniques in All Branches of Science·Ibraam E MikhailAdel Ehab Ibrahim
May 10, 2021·BMC Medical Research Methodology·Linh TranNguyen Tien Huy
Jun 3, 2021·Nutrients·Duygu AğagündüzRaffaele Capasso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Shu YuanZi-Lin Li
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia
Jordi Reina
Annual Review of Pharmacology and Toxicology
Anthony P CardileSina Bavari
Bing du xue bao = Chinese journal of virology
Xiang ZhuKanghong Hu
© 2022 Meta ULC. All rights reserved